Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
March 24, 1999
Mucocutaneous paraneoplastic syndromes (MCPS). A clinical-pathologic review
N Silvestris, G Chetta, N Sasso, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity
M A Frassanito, F Silvestris, P Cafforio, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
January 1, 1995
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]
F Silvestris, D Ribatti, B Nico, et al.
La Clinica Terapeutica
|
December 7, 2000
[Paraneoplastic syndromes of the central nervous system]
N Silvestris, A Lucarelli, P Scaringella, et al.
Cancer Treatment Reviews
|
December 7, 2010
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
F De Vita, F Giuliani, N Silvestris, et al.
Journal of Chemotherapy (Florence, Italy)
|
November 8, 2003
Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report
N Silvestris, D Piscitelli, E Crucitta, et al.
Journal of Endocrinological Investigation
|
April 19, 2023
Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center
R M Ruggeri, C C Spagnolo, A Alibrandi, et al.
Cancer Treatment Reviews
|
December 7, 2010
Lapatinib in breast cancer: clinical experiences and future perspectives
M Giampaglia, V E Chiuri, A Tinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 2014
Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM)
P Pedrazzoli, F Baldanti, I Donatelli, et al.
Clinical and Experimental Immunology
|
November 20, 1998
Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells
M A Frassanito, F Silvestris, N Silvestris, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Journal of Experimental & Clinical Cancer Research : CR
|
March 24, 1999
Mucocutaneous paraneoplastic syndromes (MCPS). A clinical-pathologic review
N Silvestris, G Chetta, N Sasso, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity
M A Frassanito, F Silvestris, P Cafforio, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
January 1, 1995
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]
F Silvestris, D Ribatti, B Nico, et al.
La Clinica Terapeutica
|
December 7, 2000
[Paraneoplastic syndromes of the central nervous system]
N Silvestris, A Lucarelli, P Scaringella, et al.
Cancer Treatment Reviews
|
December 7, 2010
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
F De Vita, F Giuliani, N Silvestris, et al.
Journal of Chemotherapy (Florence, Italy)
|
November 8, 2003
Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report
N Silvestris, D Piscitelli, E Crucitta, et al.
Journal of Endocrinological Investigation
|
April 19, 2023
Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center
R M Ruggeri, C C Spagnolo, A Alibrandi, et al.
Cancer Treatment Reviews
|
December 7, 2010
Lapatinib in breast cancer: clinical experiences and future perspectives
M Giampaglia, V E Chiuri, A Tinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 2014
Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM)
P Pedrazzoli, F Baldanti, I Donatelli, et al.
Clinical and Experimental Immunology
|
November 20, 1998
Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells
M A Frassanito, F Silvestris, N Silvestris, et al.
Page
of 6